AI Terminal
Deutsche Bank AG
Foreign Filer Report • Jul 27, 2021
99_rns_2021-07-27_2908d9bc-eed5-41a1-aad5-b33217cc114b.html
Foreign Filer Report
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information 
RNS Number : 6171G
Deutsche Bank AG
27 July 2021
Ap24
FORM 38.5(a)
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 38.5(a) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITH RECOGNISED INTERMEDIARY STATUS AND DEALING IN A CLIENT-SERVING CAPACITY
1. KEY INFORMATION
| Name of exempt principal trader | Deutsche Bank AG London |
| Company dealt in | UDG Healthcare plc |
| Class of relevant security to which the dealings being disclosed relate (Note 1) | Ordinary Shares |
| Date of dealing | 26/07/2021 |
2. DEALINGS (Note 2)
(a) Purchases and sales
| Total number of relevant securities acquired | Highest price paid (Note 3) | Lowest price paid (Note 3) |
| 3,807 | 10.7700 GBP | 10.7600 GBP |
| Total number of securities disposed | Highest price received (Note 3) | Lowest price received (Note 3) |
| 3,807 | 10.7658 GBP | 10.7658 GBP |
(b) Derivatives transactions (other than options transactions)
| Product name, e.g. CFD |
Nature of transaction (Note 4) |
Number of relevant securities (Note 5) |
Price per unit (Note 3) |
Ap25
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
| Product name, e.g. call option |
Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 5) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 3) |
(ii) Exercising
| Product name, e.g. call option |
Number of securities | Exercise price per unit (Note 3) |
3. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and
any other person relating to the voting rights of any relevant securities under any option referred to
on this form or relating to the voting rights or future acquisition or disposal of any relevant securities
to which any derivative referred to on this form is referenced. If none, this should be stated.
None
| Date of disclosure | 27/07/2021 |
| Contact name | Gurpreet Kaur Kang |
| Telephone number | +44 121 407 8493 |
| Name of offeree/offeror with which connected | Nenelite Limited |
| Nature of connection (Note 6) | Financial Adviser and Corporate Broker |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
ISEGCGDRLUDDGBR